Drug Information

Drug General Information
Drug ID
D0Z1QU
Former ID
DNC005428
Drug Name
MCL-129
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528626]
Structure
Download
2D MOL

3D MOL
Formula
C34H47FN4O
Canonical SMILES
CC(C)N1CCN(CC1)C(CN2CCN(CC2)CCCCC3=C(C=CC4=CC=CC=C43)OC<br />)C5=CC=C(C=C5)F
InChI
1S/C34H47FN4O/c1-27(2)38-22-24-39(25-23-38)33(29-11-14-30(35)15-12-29)26-37-20-18-36(19-21-37)17-7-6-10-32-31-9-5-4-8-28(31)13-16-34(32)40-3/h4-5,8-9,11-16,27,33H,6-7,10,17-26H2,1-3H3
InChIKey
SLGLZEJKMBCODK-UHFFFAOYSA-N
PubChem Compound ID
10098971
Target and Pathway
Target(s) Melanocortin-4 receptor Target Info Inhibitor [528626]
KEGG Pathway Neuroactive ligand-receptor interaction
Pathway Interaction Database Syndecan-3-mediated signaling events
Reactome Peptide ligand-binding receptors
G alpha (s) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 528626Bioorg Med Chem. 2007 Mar 1;15(5):1989-2005. Epub 2006 Dec 30.Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor.
Ref 528626Bioorg Med Chem. 2007 Mar 1;15(5):1989-2005. Epub 2006 Dec 30.Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.